Merck reported a surprise profit and beat fourth-quarter sales expectations Thursday in a move that could prod Merck stock within a buy zone.
The post Merck Reports A Surprise Profit As Keytruda Sales Continue On Their Warpath appeared first on Investor’s Business Daily.